Bruce Gewertz, MD, Cedars-Sinai surgeon-in-chief and vascular surgeon, is the principal investigator of a $4.5 million federal grant from the Department of Defense titled "OR of the Future." Along with a multidisciplinary group of investigators from Cedars-Sinai, the University of Wisconsin, the University of Washington and Madigan Army Medical Center, investigators have focused on the human factors involved in both trauma care and other emergency procedures.
Over the last five years, the vascular surgery group has published a number of investigations in health services research. Topics include extensive use of national inpatient databases to analyze variations in use of carotid endarterectomy in different regions of the country, assess changes in the treatments of abdominal aortic aneurysms and help understand drivers of the reduction in rupture rate of aneurysms in the United States.
The Vascular Surgery division is currently conducting two clinical trials:
- Descending Thoracic Aortic Aneurysm Endovascular Repair Post Approval Study (use the search term Thrive when searching Cedars-Sinai's clinical trials database)
- Evaluation of the clinical performance of the Valiant Thoracic Stent Graft with the Captivia Delivery System for the treatment of acute, complicated Type B aortic dissections (use the search term Dissection when searching Cedars-Sinai's clinical trials database)
Click here to search for all clinical trials currently being conducted at Cedars-Sinai.